Newsroom | 66111 results

WASHINGTON--(BUSINESS WIRE)--Dr. Krishnan Suthanthiran and his TeamBest Global family of companies—recognized innovators in cost-effective technologies for the diagnosis/treatment of cancer and vascular diseases, including theranostics—have issued an open call for deeper collaboration with the Association of Radiation Oncologists of India (AROI). Suthanthiran founded the International Society of Therapeutic Radiology and Oncology (ISTRO) under the Best Cure Foundation (BCF) and the Brachytherap...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on November 28, 2025. One individual was hired by Adicet in November 2025 and granted new hire non-qualified stock options to purchase 20,600 shares of Adicet’s common stock with an exercise price of $0.65 per share, the closing price of...

DUBLIN--(BUSINESS WIRE)--The "Fallopian Tube Cancer Market - A Global and Regional Analysis: Focus on Type, Treatment Type, End User, and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering. The global fallopian tube cancer market is being driven by several key factors. Rising awareness and early screening initiatives, supported by public health campaigns and improved diagnostic imaging technologies, are enabling earlier detection of gynaecologic cance...

DUBLIN--(BUSINESS WIRE)--The "Navigating ICH GCP (Good Clinical Practice) E6 (R3): What You Need to Know Training Course (Jan 29, 2026)" training has been added to ResearchAndMarkets.com's offering. This one-day training course is designed to provide clinical research professionals with a comprehensive understanding of the updated guidelines, ensuring compliance and enhancing the quality of clinical trials. The ICH GCP E6 (R3) guideline represents a significant evolution in the conduct of clini...

TORONTO--(BUSINESS WIRE)--Kayla’s Children Centre (KCC), a Thornhill-based non-profit organization dedicated to supporting children with disabilities and medical complexities, today announced the creation of Camp Lionheart, a groundbreaking, year-round camp for children with physical, developmental, behavioural, and medical needs. Located on the former site of Camp Tamarack in Muskoka, Camp Lionheart will serve as a natural extension of KCC’s mission of empowering children of all abilities to e...

カリフォルニア州サンカルロス--(BUSINESS WIRE)--（ビジネスワイヤ） -- BeOne Medicines（Nasdaq：ONC、HKEX：06160、SSE：688235）は、グローバルに展開するオンコロジー企業として、次世代BCL-2阻害薬のソンロトクラックスについて、米国食品医薬品局（FDA）が新薬承認申請（NDA）を受理し、優先審査を付与したと発表しました。本申請は、ブルトン型チロシンキナーゼ（BTK）阻害薬による治療後に再発または難治性（R/R）マントル細胞リンパ腫（MCL）がみられる成人患者を対象とするものです。 BeOneのグローバル研究開発責任者を務めるライ・ワン博士は次のように述べています。「ソンロトクラックスは、画期的治療薬指定を受けてから優先審査が付与されるまで、非常に短期間のうちに進んでいます。このように急速に進展していることの背景には、データが強固であることに加えて、R/R MCL患者にとってニーズが切迫しているという事情があります。迅速で深く、持続的な奏効に加え、管理しやすい安全性プロファイルを示すソンロトクラックスは、当社の血液疾患領域に...

MCLEAN, Va.--(BUSINESS WIRE)--Crux, the first benefits platform partnering with big pharma and employers of all sizes to expand transparent and affordable access to transformative quality-of-life (QoL) medications, today announced its public launch with $6.5 million in pre-seed funding from Red Cell Partners, a venture studio that builds rapidly scalable, technology-led companies that are bringing revolutionary advancements to market in critical industries like healthcare. U.S.-based employers...

NEW YORK--(BUSINESS WIRE)--My Mountain Mover, a leading healthcare outsourcing company, has been named the winner of two Gold awards and one Silver award in the 2025 Stevie® Awards for Women in Business. The Stevie Awards for Women in Business honor the achievements of women executives, entrepreneurs, and the organizations they lead worldwide. The awards were presented during a gala event at the Marriott Marquis Hotel in New York City and broadcast via Vimeo. More than 1,500 entries from organi...

MANHASSET, N.Y.--(BUSINESS WIRE)--Recent reports show that one in seven first responders have probable post-traumatic stress disorder (PTSD) in response to routine duties with prevalence increasing after responding to a crisis. To improve our understanding and the well-being of these essential heroes, researchers at Northwell Health’s Feinstein Institutes for Medical Research, Stony Brook University and Texas A&M University received a $3.37-million grant from the National Institute of Menta...

DUBLIN--(BUSINESS WIRE)--The "Protein Chip Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global protein chip market is poised for remarkable growth, with its size projected to expand from USD 2.15 billion in 2024 to USD 4.14 billion by 2033. This corresponds to a compound annual growth rate (CAGR) of 7.74% from 2025 to 2033. Driving this growth are factors such as the increasing prevalence of chronic diseases, including cancer, cardiovascular, and neurologica...